Details of the Drug Formulations

General Information of Drug (ID: DM0LPI9)

• Drug Name: Netarsudil Drug Info
• Synonyms: UNII-W6I5QDT7QI; W6I5QDT7QI; Netarsudil mesylate; Netarsudil [USAN]; AR-11324 free base; Netarsudil [USAN:INN]; Netarsudil (USAN/INN); GTPL9322; SCHEMBL16036278; ZINC113149554; AR11324; AR-11324; ester 60; 1628418-15-4

Indication

Disease Entry	ICD 11	Status	REF
Open-angle glaucoma	9C61	Approved	[1]
Glaucoma/ocular hypertension	9C61	Phase 2	[2]

• Cross-matching ID:
  PubChem CID: 66599893
  CAS Number: 1254032-66-0
  TTD ID: D04WYX
  ACDINA ID: D01281

Full List of Drug Formulations Containing This Drug

Netarsudil 0.2mg/ml solution

Company	Formulation ID	FDA Description
Aerie Pharmaceuticals	F23239	Boric Acid; Mannitol; Sodium Hydroxide; Water For Injection

References

• [1] 2017 FDA drug approvals.Nat Rev Drug Discov. 2018 Feb;17(2):81-85.
• [2] Effect of 0.04% AR-13324, a ROCK, and norepinephrine transporter inhibitor, on aqueous humor dynamics in normotensive monkey eyes. J Glaucoma. 2015 Jan;24(1):51-4.